Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis
Abstract Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID 50 = 0.75 ± 0.05 mg/kg...
Gespeichert in:
Veröffentlicht in: | Planta medica 2006-08, Vol.72 (10), p.899-906 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 906 |
---|---|
container_issue | 10 |
container_start_page | 899 |
container_title | Planta medica |
container_volume | 72 |
creator | Paulino, N Teixeira, C Scremin, A Dirsch, V.M Vollmar, A.M Abreu, S.R.L Castro, S.L. de Marcucci, M.C |
description | Abstract
Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID
50
= 0.75 ± 0.05 mg/kg, and in the formalin test the ID
50
values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID
50
values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC
50
values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC
50
= 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC
50
= 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter. |
doi_str_mv | 10.1055/s-2006-947185 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68839734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68839734</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</originalsourceid><addsrcrecordid>eNp10MFrFDEUBvAgit1Wj151Lnoy-jLJZCZHLa0KBQ9aPIa32ZdtSmayJjNC_evNMgs9eQgJ4cf7eB9jrwR8ENB1HwtvATQ3qhdD94RthJKGQ9uKp2wDIFsORskzdl7KPYBQBuA5OxPaQDt0w4b9uvqDccE5pKlJvpnvqMEJ455KcPW1q2cOPEw-4jjinPJDQ96Tm8uRY_M5498QA07NPhNNzSGnQ4qhvGDPPMZCL0_3Bbu9vvp5-ZXffP_y7fLTDXdq6GeuUSFtd1pT52mLvXQKTd1FoxQeQQnQWyeU1vVnp41SCKAMtZ1Q3vl-kBfs3Tq3Bv9eqMx2DMVRjDhRWorVwyBNL1WFfIUup1IyeXvIYcT8YAXYY5O22GOTdm2y-tenwct2pN2jPlVXwdsTwOIw-oyTC-XRDb3Qre6re7-6-S7QSPY-Lbk2XP6b-2blHpPFfa4jb3-0ICQIAT3U4H9G7ZJC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68839734</pqid></control><display><type>article</type><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</creator><creatorcontrib>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</creatorcontrib><description>Abstract
Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID
50
= 0.75 ± 0.05 mg/kg, and in the formalin test the ID
50
values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID
50
values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC
50
values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC
50
= 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC
50
= 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</description><identifier>ISSN: 0032-0943</identifier><identifier>EISSN: 1439-0221</identifier><identifier>DOI: 10.1055/s-2006-947185</identifier><identifier>PMID: 16902858</identifier><identifier>CODEN: PLMEAA</identifier><language>eng</language><publisher>Stuttgart: Thieme</publisher><subject>analgesic effect ; Analgesics - isolation & purification ; Analgesics - therapeutic use ; animal disease models ; Animals ; anti-inflammatory activity ; Anti-Inflammatory Agents - isolation & purification ; Anti-Inflammatory Agents - therapeutic use ; Apoidea ; Biological and medical sciences ; Brazil ; Cell Line ; Chromatography, High Pressure Liquid ; cultured cells ; Drug Evaluation, Preclinical ; edema ; enzyme inhibition ; flavonoids ; Gene Expression Regulation - drug effects ; General pharmacology ; Humans ; Inflammation - drug therapy ; Male ; Medical sciences ; Mice ; neutrophils ; nitric oxide ; nitric oxide synthase ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; nitrites ; Original Paper ; Pain - drug therapy ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; Plant Extracts - administration & dosage ; Plant Extracts - isolation & purification ; Plant Extracts - therapeutic use ; propolis ; Propolis - administration & dosage ; Propolis - chemistry ; Propolis - therapeutic use ; signal transduction ; tumor necrosis factor-alpha</subject><ispartof>Planta medica, 2006-08, Vol.72 (10), p.899-906</ispartof><rights>Georg Thieme Verlag KG Stuttgart · New York</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2006-947185.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1055/s-2006-947185$$EHTML$$P50$$Gthieme$$H</linktohtml><link.rule.ids>314,776,780,3004,3005,27901,27902,54534,54535</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18716267$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16902858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paulino, N</creatorcontrib><creatorcontrib>Teixeira, C</creatorcontrib><creatorcontrib>Scremin, A</creatorcontrib><creatorcontrib>Dirsch, V.M</creatorcontrib><creatorcontrib>Vollmar, A.M</creatorcontrib><creatorcontrib>Abreu, S.R.L</creatorcontrib><creatorcontrib>Castro, S.L. de</creatorcontrib><creatorcontrib>Marcucci, M.C</creatorcontrib><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><title>Planta medica</title><addtitle>Planta Med</addtitle><description>Abstract
Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID
50
= 0.75 ± 0.05 mg/kg, and in the formalin test the ID
50
values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID
50
values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC
50
values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC
50
= 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC
50
= 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</description><subject>analgesic effect</subject><subject>Analgesics - isolation & purification</subject><subject>Analgesics - therapeutic use</subject><subject>animal disease models</subject><subject>Animals</subject><subject>anti-inflammatory activity</subject><subject>Anti-Inflammatory Agents - isolation & purification</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Apoidea</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Cell Line</subject><subject>Chromatography, High Pressure Liquid</subject><subject>cultured cells</subject><subject>Drug Evaluation, Preclinical</subject><subject>edema</subject><subject>enzyme inhibition</subject><subject>flavonoids</subject><subject>Gene Expression Regulation - drug effects</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>neutrophils</subject><subject>nitric oxide</subject><subject>nitric oxide synthase</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>nitrites</subject><subject>Original Paper</subject><subject>Pain - drug therapy</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - administration & dosage</subject><subject>Plant Extracts - isolation & purification</subject><subject>Plant Extracts - therapeutic use</subject><subject>propolis</subject><subject>Propolis - administration & dosage</subject><subject>Propolis - chemistry</subject><subject>Propolis - therapeutic use</subject><subject>signal transduction</subject><subject>tumor necrosis factor-alpha</subject><issn>0032-0943</issn><issn>1439-0221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MFrFDEUBvAgit1Wj151Lnoy-jLJZCZHLa0KBQ9aPIa32ZdtSmayJjNC_evNMgs9eQgJ4cf7eB9jrwR8ENB1HwtvATQ3qhdD94RthJKGQ9uKp2wDIFsORskzdl7KPYBQBuA5OxPaQDt0w4b9uvqDccE5pKlJvpnvqMEJ455KcPW1q2cOPEw-4jjinPJDQ96Tm8uRY_M5498QA07NPhNNzSGnQ4qhvGDPPMZCL0_3Bbu9vvp5-ZXffP_y7fLTDXdq6GeuUSFtd1pT52mLvXQKTd1FoxQeQQnQWyeU1vVnp41SCKAMtZ1Q3vl-kBfs3Tq3Bv9eqMx2DMVRjDhRWorVwyBNL1WFfIUup1IyeXvIYcT8YAXYY5O22GOTdm2y-tenwct2pN2jPlVXwdsTwOIw-oyTC-XRDb3Qre6re7-6-S7QSPY-Lbk2XP6b-2blHpPFfa4jb3-0ICQIAT3U4H9G7ZJC</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>Paulino, N</creator><creator>Teixeira, C</creator><creator>Scremin, A</creator><creator>Dirsch, V.M</creator><creator>Vollmar, A.M</creator><creator>Abreu, S.R.L</creator><creator>Castro, S.L. de</creator><creator>Marcucci, M.C</creator><general>Thieme</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060801</creationdate><title>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</title><author>Paulino, N ; Teixeira, C ; Scremin, A ; Dirsch, V.M ; Vollmar, A.M ; Abreu, S.R.L ; Castro, S.L. de ; Marcucci, M.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-6a4aebd66e5feba73c4a99476a31fa04106bc146676ad6944a0049e2514fcf783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>analgesic effect</topic><topic>Analgesics - isolation & purification</topic><topic>Analgesics - therapeutic use</topic><topic>animal disease models</topic><topic>Animals</topic><topic>anti-inflammatory activity</topic><topic>Anti-Inflammatory Agents - isolation & purification</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Apoidea</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Cell Line</topic><topic>Chromatography, High Pressure Liquid</topic><topic>cultured cells</topic><topic>Drug Evaluation, Preclinical</topic><topic>edema</topic><topic>enzyme inhibition</topic><topic>flavonoids</topic><topic>Gene Expression Regulation - drug effects</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>neutrophils</topic><topic>nitric oxide</topic><topic>nitric oxide synthase</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>nitrites</topic><topic>Original Paper</topic><topic>Pain - drug therapy</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - administration & dosage</topic><topic>Plant Extracts - isolation & purification</topic><topic>Plant Extracts - therapeutic use</topic><topic>propolis</topic><topic>Propolis - administration & dosage</topic><topic>Propolis - chemistry</topic><topic>Propolis - therapeutic use</topic><topic>signal transduction</topic><topic>tumor necrosis factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paulino, N</creatorcontrib><creatorcontrib>Teixeira, C</creatorcontrib><creatorcontrib>Scremin, A</creatorcontrib><creatorcontrib>Dirsch, V.M</creatorcontrib><creatorcontrib>Vollmar, A.M</creatorcontrib><creatorcontrib>Abreu, S.R.L</creatorcontrib><creatorcontrib>Castro, S.L. de</creatorcontrib><creatorcontrib>Marcucci, M.C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Planta medica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paulino, N</au><au>Teixeira, C</au><au>Scremin, A</au><au>Dirsch, V.M</au><au>Vollmar, A.M</au><au>Abreu, S.R.L</au><au>Castro, S.L. de</au><au>Marcucci, M.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis</atitle><jtitle>Planta medica</jtitle><addtitle>Planta Med</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>72</volume><issue>10</issue><spage>899</spage><epage>906</epage><pages>899-906</pages><issn>0032-0943</issn><eissn>1439-0221</eissn><coden>PLMEAA</coden><abstract>Abstract
Phamacological activities of a standard ethanol extract G1 from Brazilian green propolis, typified as BRP1, was evaluated in mouse models of pain and inflammation. Intraperitoneal injection (I. P.) of G1 inhibited acetic acid-induced abdominal constrictions with an ID
50
= 0.75 ± 0.05 mg/kg, and in the formalin test the ID
50
values were 0.85 ± 0.07 mg/kg and 13.88 ± 1.12 mg/kg, respectively, for the neurogenic and inflammatory phases. The extract was ineffective when assessed in the hot-plate assay. In serotonin-induced paw edema, G1 led to a maximal inhibition (MI) of 51.6 % after 120 min when administered I. P. and of 36 % after 15 min by the oral route (O. R.). When the inflammatory agent was complete Freund’s adjuvant, inhibition of paw edema was also observed after administration of the extract by both routes. In the capsaicin-induced ear edema the ID
50
values were 1.09 ± 0.08 mg/kg (I. P.) and 10.00 ± 0.90 mg/kg (O. R.). In the acute carrageenan-induced inflammatory reaction induced by carrageenan, G1 reduced the number of neutrophils in the peritoneal cavity with IC
50
values of 0.72 ± 0.08 mg/kg and 4.17 ± 0.50 mg/kg, by I. P. or O. R. administration, with a preferential migration of polymorphonuclear neutrophils. IN VITRO, G1 decreased nitric oxide production in LPS-stimulated RAW 264.7 cells (IC
50
= 41.60 μg/mL), and also the luciferase activity in TNF-α-stimulated HEK 293 cells transfected with NF-κB-luciferase reporter gene driven by the nuclear factor κB (NF-κB) (IC
50
= 200 μg/mL). This extract, which at low concentrations induces anti-inflammatory and analgesic effects in mouse models, presents a high content of flavonoids, known to inhibit inducible NOS (iNOS) activity. These data taken together led us to reinforce the hypothesis in the literature that the anti-inflammatory effect of propolis may be a due to inhibition of iNOS gene expression, through interference with NF-κB sites in the iNOS promoter.</abstract><cop>Stuttgart</cop><cop>New York, NY</cop><pub>Thieme</pub><pmid>16902858</pmid><doi>10.1055/s-2006-947185</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0032-0943 |
ispartof | Planta medica, 2006-08, Vol.72 (10), p.899-906 |
issn | 0032-0943 1439-0221 |
language | eng |
recordid | cdi_proquest_miscellaneous_68839734 |
source | MEDLINE; Thieme Connect Journals |
subjects | analgesic effect Analgesics - isolation & purification Analgesics - therapeutic use animal disease models Animals anti-inflammatory activity Anti-Inflammatory Agents - isolation & purification Anti-Inflammatory Agents - therapeutic use Apoidea Biological and medical sciences Brazil Cell Line Chromatography, High Pressure Liquid cultured cells Drug Evaluation, Preclinical edema enzyme inhibition flavonoids Gene Expression Regulation - drug effects General pharmacology Humans Inflammation - drug therapy Male Medical sciences Mice neutrophils nitric oxide nitric oxide synthase Nitric Oxide Synthase Type II - genetics Nitric Oxide Synthase Type II - metabolism nitrites Original Paper Pain - drug therapy Pharmacognosy. Homeopathy. Health food Pharmacology. Drug treatments Plant Extracts - administration & dosage Plant Extracts - isolation & purification Plant Extracts - therapeutic use propolis Propolis - administration & dosage Propolis - chemistry Propolis - therapeutic use signal transduction tumor necrosis factor-alpha |
title | Evaluation of the analgesic and anti-inflammatory effects of a Brazilian green propolis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A25%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20analgesic%20and%20anti-inflammatory%20effects%20of%20a%20Brazilian%20green%20propolis&rft.jtitle=Planta%20medica&rft.au=Paulino,%20N&rft.date=2006-08-01&rft.volume=72&rft.issue=10&rft.spage=899&rft.epage=906&rft.pages=899-906&rft.issn=0032-0943&rft.eissn=1439-0221&rft.coden=PLMEAA&rft_id=info:doi/10.1055/s-2006-947185&rft_dat=%3Cproquest_cross%3E68839734%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68839734&rft_id=info:pmid/16902858&rfr_iscdi=true |